Table 5.
Concern over microenema use
| Group | Russia | France | ||||||
|---|---|---|---|---|---|---|---|---|
| Time | Before first use median (IQR) | After first use—median (IQR) | Percent change—median % (IQR) | Future use median (IQR) | Before first use median (IQR) | After first use—median (IQR) | Percent change—median % (IQR) | Future use median (IQR) |
| Females, 25–54 years | 5.0 (5.0) n=265 | 2.0 (4.0) | −50.0 (74.4) | 1.0 (2.0) | 6.0 (3.0) n = 280 | 4.0 (3.0) | −23.6 (65.6) | 2.0 (2.0) |
| Pregnant females, ≥ 25 years | 5.0 (6.5) n=261 | 20. (4.0) | −37.5 (80.0) | 0.0 (3.0) | NA | NA | NA | NA |
| Mothers with babies < 3 years old | 5.0 (5.8) n=260 | 1.0 (3.0) | −57.1 (88.3) | 0.0 (2.0) | NA | NA | NA | NA |
| Males and females, 60–80 years | 6.0 (4.0) n=332 | 2.5 (3.0) | −50.0 (54.9) | 1.0 (3.0) | 4.0 (3.0) n = 237 | 2.0 (1.75) | −16.7 (50.0) | 3.0 (2.0) |
| Total | 5.0 (5.0) n=1118 | 2.0 (4.0) | −50.0 (80.0) | 1.0 (2.0) | 5.0 (3.0) n = 517 | 3.0 (2.0) | −20.0 (60.0) | 2.0 (2.0) |
Scale: 0 = completely disagree; 10 = completely agree